Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.370
-0.100 (-4.05%)
At close: Oct 29, 2025, 4:00 PM EDT
2.400
+0.030 (1.27%)
After-hours: Oct 29, 2025, 7:44 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Allogeneic Chimeric Antigen Receptor - T Cell Therapies
9.99M
Log In
Log In
Log In
Log In
Upgrade
Allogeneic Chimeric Antigen Receptor - T Cell Therapies Growth
-71.01%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
9.27M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-71.71%
Log In
Log In
Log In
Log In
Upgrade
Rest of World
724.00K
Log In
Log In
Log In
Log In
Upgrade
Rest of World Growth
-57.59%
Log In
Log In
Log In
Log In
Upgrade